HALO
#799
Halozyme Therapeutics, Inc. - Common Stock
109.3 2 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.31%
Variación mensual
+32.06%
Variación en los últimos 6 meses
+56.90%
Cambio anual
+63.65%
Cierres anteriores
109.6 6
Open
108.9 5
Mínimo
108.7 4
Máximo
109.4 2
Volumen
434
Financials
- Market Capitalization 12.41 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
22.89
Relación precio/flujo de caja
5.77
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 778 |  SMMT Summit Therapeutics Inc. - Common Stock | 16.56 USD | +13.42% | +15.40% | +25.45% | -16.62% | 13.21 B USD | ||
| 793 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 545.19 USD | -0.32% | +0.40% | +10.65% | +28.70% | 12.60 B USD | ||
| 822 |  CORT Corcept Therapeutics Incorporated - Common Stock | 112.83 USD | +2.17% | -4.46% | -0.15% | +53.78% | 12.20 B USD | ||
| 825 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 85.20 USD | -0.20% | -4.38% | -2.32% | +117.90% | 12.03 B USD |